Portulaca oleracea L. in the treatment of patients with abnormal uterine bleeding: A pilot clinical trial

Phytotherapy Research

Volumn 23, Issue 10, 2009, Pages 1411-1414

  Shobeiri, S F ^a   Sharei, S ^b   Heidari, A ^c   Kianbakht, S ^d  

^a Fatemieh University of Medical Sciences   (Iran)

^b Hazrat e Abalfazl Medical Center   (Iran)

^c QOM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AVICENNA RESEARCH INSTITUTE   (Iran)

Author keywords

Abnormal uterine bleeding; Portulaca oleracea; Purslane

Indexed keywords

HERBACEOUS AGENT;

ADULT; AMENORRHEA; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; FIBROMA; FOLLOW UP; HUMAN; HUMAN TISSUE; HYSTERECTOMY; MENORRHAGIA; METRORRHAGIA; OVARY CYST; PLANT SEED; PORTULACA OLERACEA; PORTULACACEAE; PREMENOPAUSE; UTERUS BLEEDING;

ADULT; CYSTS; DRUG ADMINISTRATION SCHEDULE; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; FEMALE; HUMANS; IRAN; LEIOMYOMA; MENSTRUATION DISTURBANCES; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; PLANT PREPARATIONS; PORTULACA; POWDERS; PREMENOPAUSE; REFERENCE VALUES; SEEDS; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

PORTULACA OLERACEA; PORTULACACEAE;

EID: 70349918780     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2790     Document Type: Article

References (28)

1. Chan K, Islam MW, Kamil M et al. 2000. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol 73: 445-451. (Pubitemid 30945606)
2. Cui MZ, Liu H, Li CY. 2005. Changes of blood glucose in diabetic rats and the interventional effect of purslane. Chin J Clin Rehabil 27: 92-93. (Pubitemid 41575021)
3. Daniel M. 2006. Medicinal Plants: Chemistry and Properties. Science Publishers: Enfield (NH).
4. DerMarderosian A. 2001. Guide to Popular Natural Products, 2nd edn. Facts and Comparisons: St Louis, Missouri.
5. Evans WC. 2002. Trease and Evans Pharmacognosy, 15th edn. W.B. Saunders: Edinburgh.
6. Fu YL, Yu ZY, Tang XM et al. 2008. Pennogenin glycosides with a spirostanol structure are strong platelet agonists: Structural requirement for activity and mode of platelet agonist synergism. J Thromb Haemost 6: 524-533.
7. Guo L, Su J, Deng BW et al. 2008. Active pharmaceutical ingredients and mechanisms underlying phasic myometrial contractions stimulated with the saponin extract from Paris polyphylla Sm. var. yunnanensis used for abnormal uterine bleeding. Hum Reprod 23: 964-971. (Pubitemid 351651192)
8. Habtemariam S, Harvey AL, Waterman PG. 1993. The muscle relaxant properties of Portulaca oleracea are associated with high concentrations of potassium ions. J Ethnopharmacol 40: 195-200. (Pubitemid 24012060)
9. Istre O, Qvigstad E. 2007. Current treatment options for abnormal uterine bleeding: an evidence-based approach. Best Pract Res Clin Obstet Gynecol 21: 905-913. (Pubitemid 350177606)
10. Karimi G, Hosseinzadeh H, Ettehad N. 2004. Evaluation of the gastric antiulcerogenic effects of Portulaca oleracea L. extracts in mice. Phytother Res 18: 484-487.
11. Lim YY, Quah EPL. 2007. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem 103: 734-740. (Pubitemid 46306224)
12. Liu L, Howe P, Zhou YF et al. 2000. Fatty acids and β-carotene in Australian Purslane ( Portulaca oleracea) varieties. J Chromatogr A 893: 207-213. (Pubitemid 30657908)
13. Malek F, Boskabady MH, Borushaki MT, Tohidi M. 2004. Bronchodilatory effect of Portulaca oleracea in airways of asthmatic patients. J Ethnopharmacol 93: 57-62. (Pubitemid 38739270)
14. Miladi-Gorgi H, Vafaei AA, Rashidypour A et al. 2006. Anxiolytic effects of Portulaca oleracea aqueous extracts in mice. J Med Plants 5: 23-28. (Pubitemid 46382428)
15. Mirheidar H. 2002. Herbal Sciences, 5th edn. Islamic Culture Publication Office: Tehran.
16. Mohan S, Page LM, Higham JM. 2007. Diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynecol 21: 891-903.
17. Movahedian A, Ghannadi A, Vashirnia M. 2007. Hypocholesterolemic effects of purslane extract on serum lipids in rabbits fed with high cholesterol levels. Int J Pharmacol 3: 285-289. (Pubitemid 351330309)
18. Oh KB, Chang IM, Hwang KJ, Mar W. 2000. Detection of antifungal activity in Portulaca oleracea by a single-cell bioassay system. Phytother Res 14: 329-332. (Pubitemid 30655516)
19. Oluwole FS, Oyedeji KO. 2007. Calcium ions influences muscle relaxant response to aqueous extract of Portulaca oleracea. J Med Sci 7: 238-242.
20. Palep-Singh M, Prentice A. 2007. Epidemiology of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynecol 21: 887-890.
21. Parry O, Marks JA, Okwuasaba FK. 1993. The skeletal muscle relaxant action of Portulaca oleracea: role of potassium ions. J Ethnopharmacol 40: 187-194. (Pubitemid 24012059)
22. Radhakrishnan R, Zakaria MNM, Islam MW et al. 2001. Neuropharmacological actions of Portulaca oleracea L. v. sativa (Hawk). J Ethnopharmacol 76: 171-176. (Pubitemid 32492299)
23. Rashed AN, Afifi FU, Disi AM. 2003. Simple evaluation of the wound healing activity of a crude extract of Portulaca oleracea L. (growing in Jordan) in Mus musculus JVI-1. J Ethnopharmacol 88: 131-136.
24. Samuel NC, Clark TJ. 2007. Future research into abnormal uterine bleeding. Best Pract Res Clin Obstet Gynecol 21: 1023-1040. (Pubitemid 350185871)
25. Showstack J, Lin F, Learman LA et al. 2006. Randomized trial of medical treatment versus hysterectomy for abnormal uterine bleeding: Resource use in the Medicine or Surgery (Ms) trial. Am J Obstet Gynecol 194: 332-338. (Pubitemid 43183680)
26. Simopoulos AP, Norman HA, Gillaspy JE, Duke JA. 1992. Common purslane: A source of omega-3 fatty acids and antioxidants. J Am Coll Nutr 11: 374-382.
27. Wang W, Gu L, Dong L, Wang X, Ling C, Li M. 2007. Protective effect of Portulaca oleracea extracts on hypoxic nerve tissue and its mechanism. Asia Pac J Clin Nutr 16: 227-233. (Pubitemid 46524605)
28. Zargari A. 1997. Medicinal Plants, 4th edn. Tehran University Publications: Tehran.